Parkinson's Blog

Inspired by our late co-founder Tom Isaacs’ 4,500 mile walk around the British coast, we asked our supporters to mark 20 years of the charity with a Walk

This October, JCC Rockland is introducing classes for those diagnosed with Parkinson’s Disease. All classes are led by certified group exercise instructors with extensive experience working with people living with PD. Classes begin the week of October 6, 2025. Based on the Power for Parkinson’s guidelines, classes are led by certified group exercise instructors with […]

North Chicago: AbbVie has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tavapadon, a novel selective dopamine D1/D5 receptor…

It may be more noticeable on one side.

TV producer Rob Burley was 52 and had just lost his job at the BBC when he received his diagnosis four years ago. He reveals its impact — and what awaits him

Tavapadon is an investigational, novel, once-daily treatment option for Parkinson’s disease, which currently affects more than 1 million Americans.

Globally recognized figures like Muhammad Ali and Michael J. Fox have long suffered from Parkinson’s disease. The disease presents a complex set of

The first patient has been treated in BlueRock Therapeutics’ Phase III trial, exPDdite-2, evaluating bemdaneprocel for Parkinson’s disease.

Aidan Meyers, a senior at the University of Alabama, studied worms to uncover the function of genes associated with Parkinson’s disease.

Join Parkinson’s Support Kiama on Sunday 28 September at Black Beach for their annual Walk in the Park fundraiser. Community event featuring scenic coastal walk, BBQ, raffle prizes and raising awareness for Parkinson’s disease support services.